Published in Biopharm Drug Dispos on January 01, 2000
A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data. AAPS J (2012) 0.78
An automated process for building reliable and optimal in vitro/in vivo correlation models based on Monte Carlo simulations. AAPS J (2006) 0.75
The binding of drugs by plasma proteins. J Pharm Sci (1968) 1.69
Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry (1995) 1.63
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2007) 1.56
Detection of oxacillin-resistant staphylococci by the AutoMicrobic system. J Clin Microbiol (1983) 1.53
Novel method for studying protein binding. J Pharm Sci (1968) 1.43
Vz, the terminal phase volume: time for its terminal phase? J Biopharm Stat (2001) 1.39
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry (1984) 1.18
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. Pharmacogenetics (1999) 1.08
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol (1993) 1.03
The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J Control Release (1999) 1.02
The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm Res (1992) 1.02
Intolerance to volume expansion: a theorized mechanism for the development of preeclampsia. Obstet Gynecol (1998) 1.01
Differentiation of Rhizobium japonicum strain derivatives by antibiotic sensitivity patterns, lectin binding, and utilization of biochemicals. Can J Microbiol (1980) 1.01
Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry (1999) 1.01
Solubility versus electrostatics: what determines lipid/protein interaction in lung surfactant. Biophys J (2007) 1.00
Genetic structure of populations of Rhizoctonia solani anastomosis group-1 IA from soybean in Brazil. Phytopathology (2008) 0.96
Relating formulation variables to in vitro dissolution using an artificial neural network. Pharm Dev Technol (1997) 0.93
Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability. Pharm Res (2000) 0.92
The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets. Pharm Res (1998) 0.91
Composition and mechanics of mesenteric resistance arteries from pregnant rats. Am J Physiol (1992) 0.89
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril (1995) 0.88
Labor induction with a prenatal diagnosis of fetal macrosomia. J Matern Fetal Med (1997) 0.88
Interaction of sulfate ion with a critical tyrosine residue in yeast phosphoglycerate kinase detected through the tetranitromethane reaction. FEBS Lett (1976) 0.86
Phenytoin I: in vitro-in vivo correlation for 100-mg phenytoin sodium capsules. J Pharm Sci (1983) 0.84
Noneffect of rifampin on theophylline disposition in rabbits. Res Commun Chem Pathol Pharmacol (1982) 0.84
Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am J Obstet Gynecol (1992) 0.84
Influence of lipid saturation grade and headgroup charge: a refined lung surfactant adsorption model. Biophys J (2008) 0.84
Model-independent steady-state volume of distribution. J Pharm Sci (1982) 0.84
Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label. Clin Pharmacol Ther (2011) 0.83
In vivo-in vitro correlations with a commercial dissolution simulator II: papaverine, phenytoin, and sulfisoxazole. J Pharm Sci (1983) 0.83
The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation. Biopharm Drug Dispos (1989) 0.83
A modern view of excipient effects on bioequivalence: case study of sorbitol. Pharm Res (2006) 0.83
In vivo-in vitro correlations with a commercial dissolution simulator. I: Methenamine, nitrofurantoin, and chlorothiazide. J Pharm Sci (1981) 0.83
Variability in the bioavailability of phenytoin capsules in males and females. Pharm Res (2001) 0.82
'Pavlovian' food effect on the enterohepatic recirculation of piroxicam. Biopharm Drug Dispos (1996) 0.82
Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in rats. J Pharm Sci (1999) 0.81
The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet. Pharm Res (1991) 0.81
Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography. Clin Chem (1980) 0.81
Utilization-focused evaluation: evaluating the effectiveness of a hospital nursing orientation program. J Nurses Staff Dev (2002) 0.81
Rapid, precise, turbidometric assay for low levels of ampicillin in serum after single-dose oral administration. Antimicrob Agents Chemother (1974) 0.81
High-pressure liquid chromatographic assay for griseofulvin in plasma. J Pharm Sci (1979) 0.81
Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay. Ther Drug Monit (1985) 0.81
Effect of hyperthyroidism on hypoprothrombinemic response to warfarin. Am J Hosp Pharm (1976) 0.81
Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs. Drug Metab Dispos (1999) 0.80
The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm Res (2000) 0.80
Biopharmaceutical factors in seizure control and drug toxicity. Am J Hosp Pharm (1993) 0.79
Binding of salicylate and sulfathiazole by whole blood constituents. J Pharm Sci (1976) 0.79
Dynamic dialysis as a method for studying protein binding. I. Factors affecting the kinetics of dialysis through a cellophane membrane. J Pharm Sci (1970) 0.79
Hydrochlorothiazide. J Am Pharm Assoc (1976) 0.79
Meprobamate. J Am Pharm Assoc (1977) 0.79
Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration. Am J Obstet Gynecol (1996) 0.79
Relative bioavailability of meprobamate tablets in humans. J Pharm Sci (1978) 0.79
[Analgesic dosage with (S)-ketamine/propofol vs. (S)-ketamine/midazolam: sedation, stress response and hemodynamics--a controlled study of surgical intensive care patients]. Anasthesiol Intensivmed Notfallmed Schmerzther (2001) 0.78
Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets. Pharm Res (2001) 0.78
Xenon inhalation increases airway pressure in ventilated patients. Acta Anaesthesiol Scand (1999) 0.78
Placental transfer of chloroquine in pregnant rabbits. Res Commun Chem Pathol Pharmacol (1983) 0.78
Circadian rhythm in theophylline disposition during a constant-rate intravenous infusion of aminophylline in the dog. J Pharm Sci (1988) 0.78
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study. Ther Drug Monit (1985) 0.77
Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs. J Pharm Sci (1988) 0.77
The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function. Eur J Clin Pharmacol (1981) 0.76
Absence of effect of stimulants on the phamacokinetics of desipramine in children. Pharmacotherapy (1999) 0.76
Effect of rifampin on theophylline disposition. Ther Drug Monit (1984) 0.75
Critical questions concerning the validity of the Bayer study report of "Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration". Int J Clin Pharmacol Ther (2010) 0.75
Circadian rhythms in theophylline disposition: simulations and observations in the dog. J Pharm Sci (1991) 0.75
Bioavailability of 14 nitrofurantoin products. J Pharm Sci (1974) 0.75
Permeation of aromatic organic compounds from aqueous solutions through polyethylene. J Pharm Sci (1972) 0.75
Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans. J Pharm Sci (1985) 0.75
In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets. Biopharm Drug Dispos (1989) 0.75
Dialyzability and pharmacokinetics of indomethacin in adult patients with end-stage renal disease. Drug Intell Clin Pharm (1986) 0.75
Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems. J Pharm Sci (1970) 0.75
Bioavailability of seven furosemide tablets in man. Biopharm Drug Dispos (1986) 0.75
Hatching of Diphyllobothrium sebago eggs in nature. Trans Am Microsc Soc (1967) 0.75
Bioavailability of propylthiouracil in humans. J Pharm Sci (1983) 0.75
Gas chromatographic-mass spectrometric analysis of plasma nifedipine. J Chromatogr (1989) 0.75
The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans. Pharm Res (1993) 0.75
Sensory assessment of spreadability of hydrophilic topical preparations. J Pharm Sci (1973) 0.75
Interactions of xanthine derivatives with bovine serum albumin. 3. Inhibition of binding. J Pharm Sci (1968) 0.75
Effects of structure on permeability of substituted anilines from aqueous solutions through polyethylene. J Pharm Sci (1972) 0.75
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics. Biopharm Drug Dispos (1987) 0.75
Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men. Ann Allergy (1994) 0.75
The bioavailability of sixteen tetracycline products. J Pharmacokinet Biopharm (1974) 0.75
Bioequivalence of immediate-release theophylline capsules. Biopharm Drug Dispos (1999) 0.75
Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension. Biopharm Drug Dispos (1988) 0.75
Gas chromatographic-mass spectrometric analysis of plasma oxybutynin using a deuterated internal standard. J Chromatogr (1989) 0.75
Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system. Clin Ther (1995) 0.75
Theoretical drug levels during multiple dosing in a two-compartment open model. Arch Int Pharmacodyn Ther (1971) 0.75
Absorption of phenobarbital from tablets and elixir. J Pharm Sci (1984) 0.75
Evaluation of criteria for the recognition of Diphyllobothrium species. Trans Am Microsc Soc (1966) 0.75
The pattern of circulation of Diphyllobothrium sebago (Cestoda: Pseudophyllidea) in an enzootic area. J Wildl Dis (1972) 0.75
Providing quality drugs economically. The role of state formularies. J Am Pharm Assoc (1974) 0.75
Lack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tablets. Pharm Res (1998) 0.75